Follow
James Wason
Title
Cited by
Cited by
Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
S Sawcer, G Hellenthal, M Pirinen, CC Spencer, NA Patsopoulos, ...
3065*2011
Imaging biomarker roadmap for cancer studies
JPB O'Connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
11122017
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ...
BMC medicine 16 (1), 1-15, 2018
6812018
Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges
SS Villar, J Bowden, J Wason
Statistical Science 30 (2), 199-215, 2015
4742015
Imaging breast cancer using hyperpolarized carbon-13 MRI
FA Gallagher, R Woitek, MA McLean, AB Gill, R Manzano Garcia, ...
Proceedings of the National Academy of Sciences 117 (4), 2092-2098, 2020
1922020
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
JMS Wason, L Stecher, AP Mander
Trials 15 (1), 1-7, 2014
1782014
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
M Ban, A Goris, ÅR Lorentzen, A Baker, T Mihalova, G Ingram, DR Booth, ...
European journal of human genetics 17 (10), 1309-1313, 2009
1592009
Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
MD Witham, E Anderson, C Carroll, PM Dark, K Down, AS Hall, J Knee, ...
Trials 21 (1), 1-9, 2020
1532020
The Adaptive designs CONSORT Extension (ACE) Statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
M Dimairo, P Pallmann, J Wason, S Todd, T Jaki, SA Julious, AP Mander, ...
BMJ, 2019
1422019
A comparison of Bayesian adaptive randomization and multi‐stage designs for multi‐arm clinical trials
J Wason, L Trippa
Statistics in medicine 33 (13), 2206-2221, 2014
1242014
Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trial
P Fonagy, S Butler, D Cottrell, S Scott, S Pilling, I Eisler, P Fuggle, ...
The Lancet Psychiatry, 2018
1222018
Optimal design of multi‐arm multi‐stage trials
J Wason, T Jaki
Statistics in Medicine 31 (30), 4269-4279, 2012
1222012
Some recommendations for multi-arm multi-stage trials
J Wason, D Magirr, M Law, T Jaki
Statistical methods in medical research 25 (2), 716-727, 2016
1122016
The effect of sleep deprivation and exercise on reaction threshold in peanut-allergic adults: a randomised controlled study
S Dua, M Ruiz-Garcia, S Bond, SR Durham, I Kimber, C Mills, G Roberts, ...
Journal of Allergy and Clinical Immunology, 2019
106*2019
Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
MJ Grayling, JMS Wason, AP Mander
Trials 18, 1-13, 2017
852017
Confounding underlies the apparent month of birth effect in multiple sclerosis
B Fiddes, J Wason, A Kemppinen, M Ban, A Compston, S Sawcer
Annals of neurology 73 (6), 714-720, 2013
822013
Simple MRI score aids prediction of dementia in cerebral small vessel disease
AA Al Olama, JMS Wason, AM Tuladhar, EMC van Leijsen, M Koini, ...
Neurology 94 (12), e1294-e1302, 2020
802020
Efficient adaptive designs for clinical trials of interventions for COVID-19
N Stallard, L Hampson, N Benda, W Brannath, T Burnett, T Friede, ...
Statistics in Biopharmaceutical Research 12 (4), 483-497, 2020
762020
When to keep it simple–adaptive designs are not always useful
JMS Wason, P Brocklehurst, C Yap
BMC Medicine 17 (1), 1-7, 2019
752019
Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc …
EL Gerety, EM Lawrence, J Wason, H Yan, S Hilborne, J Buscombe, ...
Annals of Oncology 26 (10), 2113-2118, 2015
722015
The system can't perform the operation now. Try again later.
Articles 1–20